Persistence of specific humoral and cellular immunity in children after SARS-CoV-2 infection

Funding Entity Merck Sharp & Dohme, Lda

Financed Amount 67.400,00€

Consortium Hospital D. Estefânia - CHULC

Start date 2020-01-01

Final date 2023-01-01